Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.2 |
mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.059 | 0.2 |
mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.2 |